NCT00592436

Terminated

Screening Protocol for Children and Adolescents With Attenti...

Massachusetts General Hospital Source

Massachusetts General Hospital

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

2003-P-000239

Study Type

observational

Actual enrollment (reported)

663

Locations

1 country

Sites

1

Timeline

Study Start

March 2003

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

May 2015

Actual (reported)

Study Completion

May 2015

Actual (reported)

Brief Summary

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: terminated
Actual enrollment (reported): 663 participants
Study completion date: May 2015
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2003
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 28, 2007
Actual (reported)
First Posted
January 14, 2008
Actual (reported)
Primary Completion
May 2015
Actual (reported)
Study Completion
May 2015
Actual (reported)

Last Updated: May 6, 2015
Status Verified: May 2015
Last Update Submitted: May 5, 2015

Conditions

Pediatric ADHD

Keywords

ADHDpediatricchildren

Outcome Measures

Primary Outcomes (1)

Screening Protocol
This is a prescreening for potential participation in research studies.
Screening

Study Arms (1)

1

Eligibility Criteria

Age6 Years - 17 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17)

Sampling MethodNon-Probability Sample

Study Population

Children with symptoms of ADHD

You may qualify if:

Males and females ages 6-17

Sponsors & Collaborators

Massachusetts General Hospital
Otherlead

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

Joseph Biederman, MD
Massachusetts General Hospital
PRINCIPAL INVESTIGATOR

Enrollment

663 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD

Study Record Dates

First Submitted

December 28, 2007

First Posted

January 14, 2008

Study Start

March 2003

Date type not reported

This date has not been verified as actual or estimated.

Family/guardian contacting the Clinical Research Program in Pediatric Psychopharmacology, with concerns regarding ADHD symptoms in his/her child

You may not qualify if:

History of significant head trauma with loss of consciousness, organic brain disorders, seizures, or neurological intervention
Any significant medical condition, in the judgment of the investigator
Mental retardation
Pregnancy or lactation
Subjects with current, uncontrolled (within the past 3 months) illicit drug or alcohol dependence
Sensory difficulties such as deafness or blindness

Contact the study team to confirm eligibility.

Primary Completion

May 2015

Actual (reported)

Study Completion

May 2015

Actual (reported)

Last Updated

May 6, 2015

Record last verified: 2015-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00592436
Data provider: ClinicalTrials.gov
Source updated: 2015-05-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:06 UTC

Locations

US(1)

Study Stopped

Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

1

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

1

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations